CD44 and breast cancer: Additionally, the upregulation of HA-mediated motility receptor (RHAMM) promotes breast cancer progression [96], and our engineered 3D model could be used for investigating the role of RHAMM in CD44-positive breast cancer cell progression and metastasis.